Edition:
India

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

16.14USD
1:30am IST
Change (% chg)

$-1.62 (-9.12%)
Prev Close
$17.76
Open
$17.61
Day's High
$17.65
Day's Low
$16.13
Volume
295,189
Avg. Vol
270,194
52-wk High
$19.11
52-wk Low
$8.35

Chart for

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: 1.51
Market Cap(Mil.): $170.63
Shares Outstanding(Mil.): 41.42
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates